NYSE Arca · XPH

State Street SPDR S&P Pharmaceuticals ETF (XPH)

$66.89+1.21%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$66.89▲ 40.76% in range
Sep 29, 2025Low $47.32 · High $74.06Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

State Street SPDR S&P Pharmaceuticals ETF closed at $66.89 on Sep 28, up 1.21%, 9.7% below its 52-week closing high. Volume of 278.3K shares was 1.47× its 20-day average (above normal).

Split-adjusted performance: -7.6% over one month, +29.0% over six months, +46.0% over one year.

Short interest was 624.9K shares at the Sep 15 settlement, up 13.9% from the prior report (3.3 days to cover).

Market cap$551.9M8.3M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield0.25%$0.0416 last paid
52-week range45.82 – 74.06−9.7% from high
Volume278.3K1.47× 20-day avg
Volatility · 60d23.4%Annualised
Short % of float—3.3 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −0.9%1M −7.6%3M +0.7%6M +29.0%YTD +19.4%1Y +46.0%3Y +64.4%5Y +43.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short624.9K+13.9% vs prior
Days to cover3.3Settled Sep 15
% of float—
Short vol. 10d43.9%of daily volume

Quick answers

What is XPH's market cap?
$551.86M, based on the Sep 28 close of $66.89.
Does State Street SPDR S&P Pharmaceuticals ETF pay a dividend?
Yes. The latest regular dividend was $0.0416 per share (ex-date Sep 21), an annualised yield of 0.25%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology